GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Capital Point Ltd (XTAE:CPTP) » Definitions » Notes Receivable

Capital Point (XTAE:CPTP) Notes Receivable : ₪0.00 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Capital Point Notes Receivable?

Capital Point's Notes Receivable for the quarter that ended in Jun. 2024 was ₪0.00 Mil.


Capital Point Notes Receivable Historical Data

The historical data trend for Capital Point's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Capital Point Notes Receivable Chart

Capital Point Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Capital Point Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Capital Point Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Capital Point Notes Receivable Related Terms

Thank you for viewing the detailed overview of Capital Point's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Capital Point Business Description

Traded in Other Exchanges
N/A
Address
1 Azrieli Towers, Tel Aviv, ISR
Website
Capital Point Ltd is a holding company. The Company focuses its investments in technology based early stage companies in biotechnological and medical industry.